ストックスクリーナーアプリを入手
1.70
0.00%
0.00
アフターアワーズ：
1.78
0.08
+4.71%
Milestone Pharmaceuticals Inc (MIST) 最新ニュース
NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaViaReflecting the Company's Focus on Cardiometabolic Diseases - Yahoo Finance
Milestone Pharmaceuticals: Q3 Earnings Snapshot - Darien Times
Gyre Therapeutics Revenue Falls 20% as Phase 3 Trial Milestone Nears Critical Data | GYRE Stock News - StockTitan
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - The Manila Times
Milestone Pharma Trims Losses 38% as CARDAMYST Shows Strong Phase 3 Results in China | MIST Stock News - StockTitan
BridgeBio's Acoramidis Nears FDA Approval; $500M Milestone Payment Awaits | BBIO Stock News - StockTitan
Armata Pharmaceuticals Hits Key Milestone in Bacteriophage Therapy Trial, Eyes 2025 Data | ARMP Stock News - StockTitan
Milestone Pharmaceuticals Inc. (MIST) Quarterly 10-Q Report - Quartzy
Royalty Pharma Reports Third Quarter 2024 Results - ForexTV.com
Does Milestone Pharmaceuticals (NASDAQ:MIST) Have A Healthy Balance Sheet? - Simply Wall St
Head to Head Analysis: Milestone Pharmaceuticals (NASDAQ:MIST) & Alkermes (NASDAQ:ALKS) - Defense World
InnoCare Pharma (SEHK:9969) Achieves Key Milestone with ICP-488 Phase II Success in Psoriasis Treatment - Yahoo Finance
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
CNSPCNS Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Creso Pharma Limited Exceeds Milestone of 3 Million Anibidiol® Doses Sold in Europe - Marketscreener.com
Advaxis Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies - Marketscreener.com
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships - Yahoo Finance
MSD acquires cancer therapeutics developer Modifi Biosciences - Pharmaceutical Technology
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche - BioSpace
Candel therapeutics investor sells $243,834 in stock By Investing.com - Investing.com South Africa
Milestone Pharmaceuticals (NASDAQ:MIST) Earns Buy Rating from HC Wainwright - MarketBeat
Wainwright maintains Buy rating on Milestone Pharma stock By Investing.com - Investing.com UK
Millennium Management LLC Sells 105,682 Shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST) - Defense World
Individual investors account for 54% of Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) ownership, while institutions account for 46% - Yahoo Finance
IRLAB Receives Milestone Payment of USD 2.5 million in Conjunction with First Dosing in a Phase I Study with IRL757 in Healthy Older Adults - Yahoo Finance
OKUR stock soars to all-time high, reaching $20 milestone - Investing.com
NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100 - MyChesCo
1 AI Biotech Stock That Just Scored a Major Milestone - TradingView
1 AI Biotech Stock That Just Scored A Major Milestone - Barchart
Antiarrhythmic Drugs Market Size And Share Report, 2030 - Grand View Research
Candel therapeutics insider sells shares worth over $240k - Investing.com
Scientech Research LLC Invests $289,000 in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Susquehanna Fundamental Investments LLC Makes New Investment in Boston Scientific Co. (NYSE:BSX) - Defense World
MP Materials (NYSE:MP) PT Raised to $23.00 - Defense World
ProShare Advisors LLC Raises Stock Holdings in Bruker Co. (NASDAQ:BRKR) - Defense World
Toronto Dominion Bank Has $2.66 Million Position in Veeva Systems Inc. (NYSE:VEEV) - Defense World
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Sees Large Increase in Short Interest - MarketBeat
NRX-100 (Ketamine) Reaches Stability Milestone - Contract Pharma
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine) - StockTitan
Milestone Pharmaceuticals to Host Investor KOL Event - StockTitan
Milestone Pharmaceuticals (NASDAQ:MIST) Trading 0.7% Higher - Defense World
Milestone Pharmaceuticals (NASDAQ:MIST) Stock Price Up 0.7% - MarketBeat
Delaware Court of Chancery Finds Buyer Failed to Use Commercially Reasonable Efforts in Pharma Milestone Payment Case - The Harvard Law School Forum on Corporate Governance
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease - StockTitan
Citius Pharmaceuticals defers FDA milestone payment - Investing.com
Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement - Quantisnow
Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical - BioSpace
Scilex Holding (NASDAQ:SCLX) Stock Quotes, Forecast and News Summary - Benzinga
TD Cowen holds Buy on Milestone Pharmaceuticals stock, expects peak sales of $441M - Investing.com
Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones - PR Newswire
Hemogenyx Pharmaceuticals passes crucial milestone ahead of phase I trial - Proactive Investors UK
Etripamil nasal spray shows promise in China trial By Investing.com - Investing.com Australia
Etripamil nasal spray shows promise in China trial - Investing.com
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China - GlobeNewswire Inc.
Milestone Pharmaceuticals welcomes new board member Joseph Papa - Investing.com
Sonoma Biotherapeutics Receives $45 Million Milestone Payment from Regeneron under Ongoing Collaboration - Business Wire
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):